Detalhe da pesquisa
1.
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib.
Haematologica
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38813708
2.
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis.
Am J Hematol
; 99(1): 68-78, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846894
3.
Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.
Int J Mol Sci
; 24(20)2023 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37895004
4.
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis.
Am J Hematol
; 97(7): 846-855, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338671
5.
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.
Br J Haematol
; 189(2): 291-302, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31945802
6.
A challenging diagnosis of myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA rearrangement.
Blood
; 141(20): 2541, 2023 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37200055
7.
Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.
Curr Oncol Rep
; 21(11): 101, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31728739
8.
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates.
Am J Hematol
; 97(9): E347-E349, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35796725
9.
Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients.
Am J Hematol
; 92(11): 1193-1197, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28795425
10.
Thrombotic risk correlates with mutational status in true essential thrombocythemia.
Eur J Clin Invest
; 46(8): 683-9, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27271054
11.
Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
Br J Haematol
; 189(3): e104-e108, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128785
12.
Phenotypic correlates and prognostic outcomes of TET2 mutations in myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A comprehensive study of 504 adult patients.
Am J Hematol
; 95(4): E86-E89, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31925810
13.
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms.
Am J Hematol
; 95(1): E23-E26, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31659782
14.
Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP.
Am J Hematol
; 95(2): E31-E34, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31705546
15.
Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
Am J Hematol
; 94(9): E231-E234, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173385
16.
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative.
Am J Hematol
; 94(9): E239-E242, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31179561
17.
The Role of Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Past, Present, and Future Directions.
Bioengineering (Basel)
; 10(5)2023 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237661
18.
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project.
Cancer Med
; 12(7): 8166-8171, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708083
19.
A life-threatening ruxolitinib discontinuation syndrome.
Am J Hematol
; 92(8): 833-838, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28457008
20.
The safety of JAK kinase inhibitors for the treatment of myelofibrosis.
Expert Opin Drug Saf
; 20(2): 139-154, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33327810